Exane Derivatives’s Gerdau GGB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-1
Closed -$4 705
2018
Q3
$4 Sell
1
-19
-95% -$61 ﹤0.01% 687
2018
Q2
$58 Sell
20
-22,538
-100% -$78.5K ﹤0.01% 635
2018
Q1
$77.7K Sell
22,558
-3,171
-12% -$11.6K 0.02% 326
2017
Q4
$75.7K Sell
25,729
-7,607
-23% -$20.7K 0.01% 312
2017
Q3
$90.7K Sell
33,336
-30,187
-48% -$84.8K 0.02% 276
2017
Q2
$154K Sell
63,523
-14,130
-18% -$33.4K 0.03% 222
2017
Q1
$213K Sell
77,653
-25,537
-25% -$79.3K 0.05% 189
2016
Q4
$257K Sell
103,190
-15,648
-13% -$42.6K 0.05% 191
2016
Q3
$257K Sell
118,838
-57,662
-33% -$116K 0.04% 191
2016
Q2
$255K Sell
176,500
-38,466
-18% -$56.7K 0.04% 187
2016
Q1
$304K Sell
214,966
-13,454
-6% -$12K 0.04% 171
2015
Q4
$218K Sell
228,420
-17,154
-7% -$19.8K 0.03% 158
2015
Q3
$267K Buy
245,574
+37,519
+18% +$51.4K 0.03% 166
2015
Q2
$398K Buy
208,055
+101,430
+95% +$244K 0.04% 159
2015
Q1
$271K Sell
106,625
-48,690
-31% -$135K 0.03% 183
2014
Q4
$438K Buy
+155,315
New +$515K 0.06% 153

Other funds holding GGB

Exane Derivatives's GGB Position: Q4 2018 in Review

Exane Derivatives sold out of Gerdau (GGB) in Q4 2018, closing a stake of 1 share — an estimated $4 sold.

Exane Derivatives first reported a position in GGB in Q4 2014 and held it in 16 quarters. The position peaked at $438K in Q4 2014. 140 funds tracked by Wall St. Rank hold GGB as of Q4 2018.

  • Exane Derivatives reported no remaining Gerdau position as of Q4 2018 after selling out during the quarter.
  • Exane Derivatives sold 1 Gerdau share in Q4 2018, an estimated $4.
  • Exane Derivatives first reported a position in Gerdau in Q4 2014 and held it in 16 quarters.
  • Exane Derivatives's Gerdau position peaked at $438K in Q4 2014.
  • 140 funds tracked by Wall St. Rank held Gerdau as of Q4 2018.

Based on Exane Derivatives's 13F filing for Q4 2018, filed 31 Jan 2019.